Overview: Q Fever Antibody Panel TestIntroduction: The Q Fever Antibody Panel Test detects Q fever antibodies to diagnose Coxiella infection, causing fever or pneumonia. Aligned with 2023 IDSA guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected Q fever.
Other Names: Q Fever Ab Assay, Coxiella burnetii Antibody Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Q fever antibody testing began in the 1940s with zoonotic disease research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Q fever IgG and IgM antibodies to diagnose Coxiella infection, guides treatment, and evaluates patients with fever or pneumonia.
Test Parameters: 1. Q Fever IgG & IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, pneumonia, or exposure to livestock.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, pneumonia, or history of zoonotic exposure. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, Q fever implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect Q fever IgG and IgM antibodies. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for Q fever diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Early testing may yield false negatives.
Clinical Significance: Positive IgM indicates acute Q fever, guiding doxycycline therapy. Positive IgG suggests past infection, requiring clinical correlation.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: Q fever PCR, chest X-ray, or liver function tests to confirm Coxiella infection diagnosis.
Test Limitations: Non-specific for certain infections; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA Q Fever Guidelines, 2023; Clinical Infectious Diseases, Anderson A, 2022.
